Annual EBITDA
-$2.60 M
-$1.38 M-112.10%
31 December 2022
Summary:
Serina Therapeutics annual earnings before interest, taxes, depreciation & amortization is currently -$2.60 million, with the most recent change of -$1.38 million (-112.10%) on 31 December 2022. During the last 3 years, it has fallen by -$1.38 million (-112.10%). SER annual EBITDA is now -112.10% below its all-time high of -$1.23 million, reached on 01 December 2021.SER EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$5.21 M
-$1.40 M-36.56%
30 September 2024
Summary:
Serina Therapeutics quarterly earnings before interest, taxes, depreciation & amortization is currently -$5.21 million, with the most recent change of -$1.40 million (-36.56%) on 30 September 2024. Over the past year, it has dropped by -$3.91 million (-299.85%). SER quarterly EBITDA is now -449.42% below its all-time high of -$949.00 thousand, reached on 31 March 2023.SER Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$11.33 M
-$3.91 M-52.71%
30 September 2024
Summary:
Serina Therapeutics TTM earnings before interest, taxes, depreciation & amortization is currently -$11.33 million, with the most recent change of -$3.91 million (-52.71%) on 30 September 2024. Over the past year, it has dropped by -$9.07 million (-402.80%). SER TTM EBITDA is now -1093.68% below its all-time high of -$949.00 thousand, reached on 31 March 2023.SER TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SER EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -299.9% | -402.8% |
| 3 y3 years | -112.1% | - | - |
| 5 y5 years | - | - | - |
SER EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -112.1% | at low | -449.4% | at low | -1093.7% | at low |
| 5 y | 5 years | -112.1% | at low | -449.4% | at low | -1093.7% | at low |
| alltime | all time | -112.1% | at low | -449.4% | at low | -1093.7% | at low |
Serina Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.21 M(+36.6%) | -$11.33 M(+52.7%) |
| June 2024 | - | -$3.82 M(+66.3%) | -$7.42 M(+106.1%) |
| Mar 2024 | - | -$2.30 M(+76.1%) | -$3.60 M(+59.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$1.30 M(+37.4%) | -$2.25 M(+137.4%) |
| Mar 2023 | - | -$949.00 K | -$949.00 K |
| Dec 2022 | -$2.60 M(+112.1%) | - | - |
| Dec 2021 | -$1.23 M | - | - |
FAQ
- What is Serina Therapeutics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Serina Therapeutics?
- What is Serina Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Serina Therapeutics?
- What is Serina Therapeutics quarterly EBITDA year-on-year change?
- What is Serina Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Serina Therapeutics?
- What is Serina Therapeutics TTM EBITDA year-on-year change?
What is Serina Therapeutics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of SER is -$2.60 M
What is the all time high annual EBITDA for Serina Therapeutics?
Serina Therapeutics all-time high annual earnings before interest, taxes, depreciation & amortization is -$1.23 M
What is Serina Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of SER is -$5.21 M
What is the all time high quarterly EBITDA for Serina Therapeutics?
Serina Therapeutics all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$949.00 K
What is Serina Therapeutics quarterly EBITDA year-on-year change?
Over the past year, SER quarterly earnings before interest, taxes, depreciation & amortization has changed by -$3.91 M (-299.85%)
What is Serina Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of SER is -$11.33 M
What is the all time high TTM EBITDA for Serina Therapeutics?
Serina Therapeutics all-time high TTM earnings before interest, taxes, depreciation & amortization is -$949.00 K
What is Serina Therapeutics TTM EBITDA year-on-year change?
Over the past year, SER TTM earnings before interest, taxes, depreciation & amortization has changed by -$9.07 M (-402.80%)